The 20 Best Immune Thrombocytopenic Purpura (ITP) Doctors in Utah, US

Scott Samuelson is an Oncologist in Salt Lake City, Utah. Dr. Samuelson is rated as an Advanced provider by MediFind in the treatment of Immune Thrombocytopenic Purpura (ITP). His top areas of expertise are Muscle Invasive Bladder Cancer, Non-Muscle Invasive Bladder Cancer, Familial Colorectal Cancer, and Non-Hodgkin Lymphoma. Dr. Samuelson is currently accepting new patients.

Nitin Chandramouli is an Oncologist in Salt Lake City, Utah. Dr. Chandramouli is rated as an Advanced provider by MediFind in the treatment of Immune Thrombocytopenic Purpura (ITP). His top areas of expertise are Immune Thrombocytopenic Purpura (ITP), Adult Immune Thrombocytopenia, Agranulocytosis, and Essential Thrombocythemia. Dr. Chandramouli is currently accepting new patients.

Stephan Kendall is an Oncologist in West Valley City, Utah. Dr. Kendall is rated as an Advanced provider by MediFind in the treatment of Immune Thrombocytopenic Purpura (ITP). His top areas of expertise are Thrombocytopenia, Drug-Induced Thrombocytopenia, Agranulocytosis, Chronic Familial Neutropenia, and Bone Marrow Aspiration. Dr. Kendall is currently accepting new patients.

Dr. Pyper is currently an assistant professor at the University of Utah School of Medicine in the division of Pediatric Hematology/Oncology. He is a member of the Hematology team at the University of Utah and Primary Children's Hospital. He received his medical degree from Northwestern University Feinberg School of Medicine.Dr. Pyper completed his residency at the University of Vermont College of Medicine, University of Vermont Children's Hospital (Pediatrics). He completed his fellowship in Pediatric Hematology, Oncology and Bone Marrow Transplantation at the University of Minnesota Medical School, University of Minnesota Masonic Children's Hospital.Dr. Pyper is board-certified in Pediatrics and Pediatric Hematology and Oncology. He is a member of many professional societies, including The American Society of Pediatric Hematology/Oncology, The American Society for Hematology and the American Society for Transplantation and Cellular Therapy. He has many years teaching experience and has previously been awarded teacher of the year by the associated pediatric residency program. He also takes great interest in patient and family education to make sure that patients and families understand their medical issues in an age-appropriate way so that they are able to participate in decision-making and advocate well for themselves and their loved ones.Dr. Pyper's clinical interests include the treatment of pediatric disorders including non-malignant hematology, disorders of hemostasis and thrombosis, sickle cell disease, red cell membrane defects and hemoglobinopathies as well as bone marrow failure syndromes.His primary research interests include congenital and acquired risk factors for abnormal bleeding and clotting in pediatric patients as well as improving access to needed health care resources for high-risk pediatric patients affected by hematologic diseases. Dr. Pyper is rated as an Experienced provider by MediFind in the treatment of Immune Thrombocytopenic Purpura (ITP). His top areas of expertise are Hereditary Spherocytosis, Hemolytic Anemia, Acute Lymphoblastic Leukemia (ALL), and Congenital Hemolytic Anemia.

Richard Lemons, MD, PhD, is a professor in the Department of Pediatrics at the University of Utah School of Medicine, medical director and chief of pediatric hematology/oncology at Primary Children's Medical Center and the University of Utah, and a Huntsman Cancer Institute investigator. He is involved in various clinical trials for pediatric malignancies and pediatric hematologic disorders.Lemons earned a medical degree from George Washington University School of Medicine, Washington, DC; and performed an internship and residency at Johns Hopkins Hospital, Baltimore. Lemons was a staff member at St. Jude Children's Research Hospital prior to joining the University of Utah Department of Pediatrics. He is board certified in Pediatrics and Pediatric Hematology-Oncology. Dr. Lemons is rated as an Experienced provider by MediFind in the treatment of Immune Thrombocytopenic Purpura (ITP). His top areas of expertise are Hemophilia B, Infantile Neutropenia, Blood Clots, and Febrile Neutropenia.

Dr. Ford is currently an associate professor at the University of Utah School of Medicine in the division of Pediatric Hematology/Oncology. He is a member of the Leukemia and Lymphoma Team at the University of Utah and Primary Children's Hospital. He received his medical degree from Des Moines University College of Osteopathic Medicine.Dr. Ford completed his residency at Akron Children's Hospital specializing in Pediatrics. He pursued his Hematology, Oncology and Bone Marrow Transplantation Fellowship at the University of Colorado School of Medicine, Children's Hospital Colorado.Dr. Ford is board-certified in Pediatrics and Pediatric Hematology and Oncology. He has authored several articles in peer-reviewed journals and has been the principal investigator in several grants.Dr. Ford's clinical interests include the treatment of pediatric Leukemia and Lymphoma. He has an emphasis in post-transplant lymphoproliferative disorder and Non-Hodgkin Lymphomas.His primary research focuses on Non-Hodgkin Lymphoma. He is involved in clinical trials for relapsed T-cell lymphoblastic lymphoma and relapsed mature B cell lymphoma. He is also interested in discovering risk factors leading to relapse in T-cell lymphoblastic lymphoma. . His top area of expertise is Immune Thrombocytopenic Purpura (ITP).

Dr. Dietz received his degrees in medicine and medical education from the University of New England. He completed his Pediatric Residency and Hematology and Oncology Fellowship at Oregon Health & Science University where he also served as chief resident.In 2020 Dr. Dietz joined the faculty of the University of Utah, where he is currently an Assistant Professor of Pediatrics in the Division of Pediatric Hematology and Oncology. Clinically, Dr. Dietz focuses on the care of pediatric and young adult patients with bone and soft tissue sarcoma, as well as children with retinoblastoma. He is the Associate Director of the Primary Children's Hospital Solid Tumor Program and leads the Comprehensive Retinoblastoma Program. Dr. Dietz is committed to delivering cutting edge clinical care, as well as providing patients with access to experimental therapeutics and discovery programs. Dr. Dietz's research efforts include team science approaches to better understand the biology driving cancer progression and treatment resistance with a focus on translating this work into new therapies. He is a member of the Huntsman Cancer Institute's Experimental Therapeutics Program and actively involved in the development of early phase clinical trials through multiple cooperative consortia including the Children's Oncology Group, The Sunshine Project, the Pediatric Oncology Experimental Therapeutics Investigator's Consortium, and the Pediatric Early Phase Clinical Trial Network. . His top areas of expertise are Ewing Sarcoma, Langerhans Cell Histiocytosis, Reticulohistiocytoma, Histiocytosis, and Bone Marrow Aspiration.

Dr. Goteti received his medical degree from Ross University School of Medicine, completed his Pediatric residency at Golisano Children's Hospital at SUNY Upstate Medical University, where he also served as a chief resident, and his Hematology-Oncology Fellowship at Oregon Health and Science University.Dr. Goteti is an Assistant Professor in the division of Pediatric Hematology/Oncology/BMT at the University of Utah School of Medicine. His clinical interests are hemoglobinopathies, immune-hematology, bone marrow failure syndromes, and platelet disorders. He serves as the institutional lead in sickle cell disease and thalassemia. He is the site PI for the Pacific Sickle Cell Regional Collaborative (PSCRC) and the Globin Regional Data and Discovery (GRANDaD) studies. He leads multiple quality improvement initiatives and recently received the American Society of Hematology Quality Improvement Training Initiative award. . His top areas of expertise are Shwachman-Diamond Syndrome, Infantile Neutropenia, and Immune Thrombocytopenic Purpura (ITP).

Dr. Casey Mehrhoff received her Master of Science in Biomedical Sciences and medical degree from Kansas City University of Medicine, completed her Pediatric Residency at Loyola University Medical Center in Chicago, and her Pediatric Hematology/Oncology Fellowship at Ann & Robert H. Lurie Children's Hospital of Chicago. She is currently an Assistant Professor of Pediatrics at the University of Utah within the Division of Pediatric Hematology/Oncology at Primary Children's Hospital. Her clinical focus is on pediatric patients with solid tumor malignancies, with a specific focus on patients diagnosed with rare tumors and patients with cancer predisposition syndromes. She is the co-director and co-founder of the Pediatric Multidisciplinary Thyroid Team and is the co-director and founder of the Pediatric Multidisciplinary Melanoma program and is involved with these specialties on a national level. She is a provider in the high risk genetics cancer predisposition clinic at Huntsman Cancer Institute where she provides care and cancer screening for patients with certain cancer predisposition syndromes, such as Li Fraumeni Syndrome, DICER1, and Familial Adenomatous Polyposis, to name a few. Her research interest is in translational research and clinical trials. . Her top areas of expertise are Neuroblastoma, Embryonal Tumor with Multilayered Rosettes, Acute Lymphoblastic Leukemia (ALL), and Immune Thrombocytopenic Purpura (ITP).

Dr. Chan received her medical degree from the University of Minnesota Medical School, completed her Pediatric Residency at the University of Wisconsin, and her Pediatric Hematology/Oncology Fellowship at the University of Utah. Following fellowship she completed a Pediatric Neuro-Oncology Fellowship at the University of Colorado/Children's Hospital Colorado.Dr. Chan is currently an Assistant Professor of Pediatrics at the University of Utah in the Division of Pediatric Hematology/Oncology. She is a member of the neuro-oncology team at Primary Children's Medical Center.Dr. Chan's clinical interests include the care of children and young adults with brain and spine tumors. Dr. Chan's research interests are focused on the development of early phase clinical trials for children with central nervous system tumors and the long-term care of patients who have survived these cancers. . Her top areas of expertise are Glioma, Medulloblastoma, Embryonal Tumor with Multilayered Rosettes, and Immune Thrombocytopenic Purpura (ITP).

Dr. Dolan received his medical degree from the University of Washington and completed his Pediatric residency at Seattle Children´s Hospital.  He went on to pursue his Pediatric Hematology and Oncology Fellowship and advanced fellowship in cellular/immunotherapy and bone marrow transplant at the Children's Hospital of Philadelphia. He joined the faculty of the University of Utah in 2021 as an Assistant Professor of Pediatrics in the Division of Pediatric Hematology and Oncology.Dr. Dolan's clinical interests include the treatment of pediatric disorders requiring bone marrow transplant.  He has an emphasis on high-risk hematologic malignancies and cellular therapy designed to reduce toxicity in patients with relapsed and refractory disease.His primary research focuses on outcomes of children treated with cellular/immunotherapy products. He also has an interest in understanding the emotional and spiritual challenges that arise as part of the journey for patients and families diagnosed with cancer. . His top areas of expertise are Hereditary Neuroblastoma, Neuroblastoma, Acute Lymphoblastic Leukemia (ALL), and Immune Thrombocytopenic Purpura (ITP).

Acute Leukemia and Lymphoma and blood and marrow/Stem cell transplant.Professional interests: Adolescent and Young Adults, Acute Lymphoblastic Leukemia. Personal interests: Skiing, biking, music. . Her top areas of expertise are Acute Myeloid Leukemia (AML), Acute Myeloblastic Leukemia without Maturation, Myelodysplastic Syndrome (MDS), Bone Marrow Aspiration, and Bone Marrow Transplant.

Dr. Thomsen received his medical degree from the University Of Virginia School Of Medicine.  He completed a residency in general pediatrics at Wake Forest Baptist Medical Center where he also served as chief resident and practiced as a pediatric hospitalist.  He completed his clinical fellowship in pediatric hematology and oncology at the University of Utah.  He is currently an Assistant Professor in the Pediatric Hematology and Oncology Division at the University of Utah.Dr. Thomsen's clinical interests include care of children with childhood leukemia, lymphoma and various other cancers.  Dr. Thomsen's research focuses on improving care of children with childhood cancer by applying quality improvement principles to everyday care.  He is passionate about medical education and improving hematology-oncology education in pediatric residency programs and has a keen interest in improving access to pediatric hematology-oncology services throughout the intermountain west. . His top areas of expertise are Acute Lymphoblastic Leukemia (ALL), Glioma, Hereditary Neuroblastoma, and Neuroblastoma.

Dr. Fraley received her medical degree from the University of New Mexico School of Medicine, followed by a Pediatrics residency at Oregon Health & Science University. She then completed a Pediatric Hematology, Oncology, and Bone Marrow Transplant fellowship at Children's Hospital Colorado where she received additional training in clinical research through the Masters of Clinical Science program at the University of Colorado Anschutz Medical Campus. Dr. Fraley was an Instructor of Pediatrics for an additional year at Children's Hospital Colorado, where she continued to care for patients while also developing a program of research studying neurocognitive outcomes in children with cancer and blood disorders.Dr. Fraley is currently an Assistant Professor of Pediatrics at the University of Utah and is in the Division of Pediatric Hematology Oncology. Clinically, she cares for patients with leukemia and lymphoma as well as long term survivors of all cancers. Dr. Fraley's program of research examines neurocognitive dysfunction (i.e., difficulties with thinking, learning, and remembering) in childhood cancer survivors, including risk factors for dysfunction, the consequences of dysfunction, and interventions to prevent decline. . Her top areas of expertise are Acute Lymphoblastic Leukemia (ALL) and Immune Thrombocytopenic Purpura (ITP).

Dr. Mangum received his medical degree from the Albert Einstein College of Medicine (affiliated with Yeshiva University). He then completed his Pediatric residency at Primary Children´s Hospital (affiliated with the University of Utah), which was followed by a pediatric Hematology Oncology Fellowship at St Jude Children's Research Hospital (affiliated with the University of Tennessee). Afterwards, he completed an additional two year Physician Scientist Training Program fellowship at St. Jude Children's Research Hospital while still also continuing to care for patients. Following this, Dr. Mangum joined the faculty of Nemours Children's Hospital in Delaware where he practiced for three years in pediatric hematology oncology. Dr. Mangum then joined the University of Utah in the Division of Pediatric Hematology Oncology at Primary Children's Hospital. Dr. Mangum's research interests have focused primarily on Acute Lymphoblastic Leukemia, with his clinical interests focused on patients with Leukemias, Lymphomas, and histiocytic disorders of all kinds. However, he is comfortable with caring for any patient across the entire pediatric hematology oncology spectrum. . His top areas of expertise are Acute Lymphoblastic Leukemia (ALL), Leukemia, Rosai-Dorfman Disease, and Immune Thrombocytopenic Purpura (ITP).

Dr. McNeer is a Professor of Clinical Pediatrics at the University of Utah School of Medicine in the Division of Pediatric Hematology/Oncology and is the Medical Director for Pediatric Hematology/Oncology at Primary Children's Hospital. She is a member of the Leukemia and Lymphoma team at the University of Utah and Primary Children's Hospital.After receiving her medical degree from New York University School of Medicine, Dr. McNeer completed her residency at Children's Memorial Hospital (now Lurie Children's Hospital), which is affiliated with Northwestern University Feinberg School of Medicine. She then completed her fellowship in Pediatric Hematology/Oncology/Stem Cell Transplant at Children's Memorial Hospital, and during her fellowship earned a master's degree in clinical investigation at Northwestern University Feinberg School of Medicine.Dr. McNeer is board-certified in Pediatrics and Pediatric Hematology and Oncology. She has authored over 25 peer-reviewed journal articles and 4 book chapters. Dr. McNeer has been an invited speaker at many national and international conferences and symposiums. She is a member of the American Society of Clinical Oncology, American Society of Hematology, as well as the American Society of Pediatric Hematology/Oncology and the Children's Oncology Group.Dr. McNeer's clinical expertise is in the treatment of children, adolescents, and young adults with hematologic malignancies such as leukemia and lymphoma, in particular those with high-risk and relapsed/refractory acute lymphoblastic leukemia. She has a leadership role within the Children's Oncology Group Acute Lymphoblastic Leukemia committee, and partners with colleagues in adult oncology to collaborate in developing treatment protocols and clinical trials for young adults with leukemia. Her research focus is on the design and implementation of clinical trials for patients with hematologic malignancies.Dr. McNeer is invested in improving overall treatment outcomes for children, adolescents, and young adults, while tailoring therapy and supportive care to individual patients in order to minimize toxicity and optimize quality of life. . Her top areas of expertise are Acute Lymphoblastic Leukemia (ALL), Leukemia, Febrile Neutropenia, Infantile Neutropenia, and Bone Marrow Aspiration.

Xylina Gregg is an Oncologist in Salt Lake City, Utah. Dr. Gregg is rated as an Experienced provider by MediFind in the treatment of Immune Thrombocytopenic Purpura (ITP). Her top areas of expertise are Breast Cancer, Paget Disease of the Breast, Vulvar Cancer, and Familial Colorectal Cancer. Dr. Gregg is currently accepting new patients.

Nathan Rich is an Oncologist in Salt Lake City, Utah. Dr. Rich is rated as an Experienced provider by MediFind in the treatment of Immune Thrombocytopenic Purpura (ITP). His top areas of expertise are Thrombotic Thrombocytopenic Purpura, Small Cell Lung Cancer (SCLC), Chronic Lymphocytic Leukemia (CLL), and Paget Disease of the Breast. Dr. Rich is currently accepting new patients.

Nicholas Thomson is an Internal Medicine provider in Lehi, Utah. Dr. Thomson is rated as an Experienced provider by MediFind in the treatment of Immune Thrombocytopenic Purpura (ITP). His top areas of expertise are Thrombocytopenia, Paget Disease of the Breast, Inflammatory Breast Cancer, and Breast Cancer. Dr. Thomson is currently accepting new patients.

Trevor Memmott is a Pediatrics provider in Salt Lake City, Utah. His top area of expertise is Immune Thrombocytopenic Purpura (ITP). Dr. Memmott is currently accepting new patients.